In the late 1970s in Japan, use of anti-HBe as a marker for low infectivity had been based on the observation (17) that anti-HBe–seropositive carriers were unlikely to transmit hepatitis B sexually or to their infants. This evidence concerns the gene HBE1 and hepatitis B virus infection.